BATS | ETF
The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole.
The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| VERV | Verve Therapeutics Inc | Healthcare | Biotechnology | 5.08% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 4.92% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 4.53% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 3.37% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 3.20% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 2.83% |
| NOVO-B | Novo Nordisk A/S | Healthcare | Drug Manufacturers - General | 2.35% |
| DAR | Darling Ingredients Inc | Consumer Defensive | Packaged Foods | 2.32% |
| IMNM | Immunome Inc | Healthcare | Biotechnology | 2.25% |
| TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 2.25% |
| STOK | Stoke Therapeutics Inc | Healthcare | Biotechnology | 2.16% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.15% |
| BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 2.05% |
| FOLD | Amicus Therapeutics Inc | Healthcare | Biotechnology | 2.05% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 2.04% |
| AZN_old | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 2.04% |
| BG | Bunge Global SA | Consumer Defensive | Farm Products | 2.03% |
| CTVA | Corteva Inc | Basic Materials | Agricultural Inputs | 2.02% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 2.02% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 1.99% |